
Reviewer Board
Members of the reviewer board are selected from all Pharmaceutics reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
Interests: novel drug delivery systems of poorly water soluble drugs; antifungals and antiparasitic drugs; 3D printing of medicine
Interests: skin and nail care product development and characterization; rheology; microstructure; skin permeation mechanisms and in vitro and in vivo efficacy and safety tests
Interests: computational biology; tissue engineering; organoids; cardiology; Immunology; bioprinting; biomaterials; Bioinformatics; gastrointestinal
Interests: endocytosis; toxin; siRNA; antisense; gene therapy; gene editing; CRISPR-Cas9; cell biology
Interests: pharmacology; immunopharmacology; inflammation; cancer; neurodegenerative diseases; stroke; regulatory science
Interests: cardiovascular; biomarkers; endothelium; microvasculature; inflammation; oxidative stress; hemodynamics
Interests: retina; retinal diseases; retinal degeneration; macular degeneration; retinal ganglion cells; glaucoma
Interests: HIV; influenza; SARS-CoV2; COVID-19; AIDS; B cell receptor sequencing; immunity; vaccination
Interests: oral delivery; fixed dose combination products; particle engineering for pulmonary and nasal delivery; solid state characterization
Interests: Virus like particles; nanomaterials; nanotubes; nanoparticles; cartilage regeneration; tissue engineering; 3D bioprinting; Applied Biotechnology
Interests: paediatric; formulation; excipients; low resource settings; medicines for children; administration devices; age appropriate formulations
Interests: polymers; glasses; solid dispersions; Dielectric spectroscopy; materials science
Interests: drug delivery; targeting; nanomedicines; nanoemulsions; intranasal; nose-to-brain; cancer; RalGPS2
Interests: antioxidants; drug delivery; nanocarriers; skin permeation; colloidal system; FFF technique
Interests: nanoparticle; liposome; immunotherapy; chemotherapy; targeted nanoparticle; EPR; cancer
Interests: vibrational spectroscopy; multivariate analysis; drug delivery; crystal engineering; pharmaceutical formulations; cocrystals; co-amorphous
Interests: drug delivery system; pharmacokinetic control; micro- and nano- particle design; biopharmaceuticals
Interests: vaccines; influenza virus; infectious diseases; monoclonal antibodies; antibody response
Interests: inner ear drug delivery systems; pharmacokinetics; cochlear implant optimization; fibrosis reduction; growth factors; neuroregeneration
Interests: zebrafish; muscular dystrophy; pancreatic cancer; cell signaling; CRISPR/Cas9; Ca2+ signaling; mitochondria; HIV-1 vaccine; tumor immunotherapy; drug screening; molecular biology
Interests: magnetic nanoparticles; iron oxides; characterization; bio-nano-interactions; nanomaterials
Interests: drug metabolism; cytochrome P450 enzymes; protein biochemistry; structural biology
Interests: oral drug delivery; nanoparticle; gene therapy; immunology; diabetes; osteoporosis; cancer; hydrogel; vaccine
Interests: vaccines; animal model; allergy vaccines; immuno-therapy; autoimmune disorders; drug delivery; skin based approaches for vaccine/drug delivery; tissue engineering; biomaterials
Interests: tissue engineering; drug delivery; nanomedicine; formulation; antibody drug conjugate; biomaterials; PK/PD
Interests: pharmaceutical cocrystals; solid-state characterization; crystalline; amorphous systems; pre-formulation studies; single-crystal studies; polymorphism, particle and crystal engineering; nano-crystalline dispersions; amorphous solid dispersions; spray drying; extrusion; particle characterization,; ionic liquids
Interests: drug delivery; biomaterials; 3D fabrication; nanomedicine
Interests: pharmacokinetics; PBPK modeling; clinical trials; pharmacometabolomics; pharmacogenomicsze
Interests: pharmacokinetics; pharmacodynamics; modeling and simulation; biopharmaceutics
Interests: drug transporter; drug metabolism; Pharmacokinetics; metabolic disorder; Pharmacogenomics; drug development